TD Cowen and RBC provided rating and price target updates for Aptiv stock, with MarketBeat aggregating the consensus data.
3 reports, 1 independent
Updated Sep 15
Gone quiet
- Reports
- 3
- Developments
- 1
- Repetition
- 67%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
TD Cowen and RBC provided rating and price target updates for Aptiv stock, with MarketBeat aggregating the consensus data.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Aptiv
automotive parts technology company
Nothing else this week.
-
TD Cowen
American investment bank
-
Royal Bank of Canada
financial institution in Canada
Related events
- MarketBeat published average ratings and price targets for Kalaris Therapeutics, while Citigroup reaffirmed an outperform rating and TD Cowen initiated coverage with a buy rating.
- Analyst firms Jefferies and TD Cowen upgraded their ratings for Forgent Power Solutions, Inc., while MarketBeat provided consensus data.
- MarketBeat reports consensus ratings from sixteen brokerages, including RBC's 'outperform' rating and Scotiabank's target price cut for Lightspeed.
- Analyst firms RBC and Morgan Stanley set price targets for OTIS, with MarketBeat aggregating the ratings.
- RBC invested in BOSC shares, and MarketBeat provided a consensus rating for the company.